Axel Benner

43.5k total citations · 6 hit papers
398 papers, 24.1k citations indexed

About

Axel Benner is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Axel Benner has authored 398 papers receiving a total of 24.1k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Molecular Biology, 130 papers in Oncology and 108 papers in Hematology. Recurrent topics in Axel Benner's work include Multiple Myeloma Research and Treatments (56 papers), Acute Myeloid Leukemia Research (45 papers) and Chronic Lymphocytic Leukemia Research (42 papers). Axel Benner is often cited by papers focused on Multiple Myeloma Research and Treatments (56 papers), Acute Myeloid Leukemia Research (45 papers) and Chronic Lymphocytic Leukemia Research (42 papers). Axel Benner collaborates with scholars based in Germany, United States and United Kingdom. Axel Benner's co-authors include Hartmut Döhner, Peter Lichter, Stephan Stilgenbauer, Konstanze Döhner, Lars Bullinger, Alexander Kröber, Martin Bentz, Richard F. Schlenk, Elke Leupolt and Stefan Fröhling and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Axel Benner

389 papers receiving 23.7k citations

Hit Papers

Genomic Aberrations and S... 1995 2026 2005 2015 2000 2008 1997 2002 2002 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
    2000 2.3k citations Hartmut Döhner, Axel Benner et al. profile →
  2. Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
    2008 1.1k citations Konstanze Döhner, Lars Bullinger et al. profile →
  3. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
    1997 699 citations Axel Benner, Hartmut Döhner et al. profile →
  4. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm
    2002 660 citations Axel Benner, Hartmut Döhner et al. Blood profile →
  5. V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
    2002 597 citations Axel Benner, Lars Bullinger et al. Blood profile →
  6. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
    1995 576 citations Axel Benner, Peter Lichter et al. Blood profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Axel Benner 9.7k 7.5k 6.4k 6.1k 5.4k 398 24.1k
Giovanni Martinelli 8.0k 0.8× 8.0k 1.1× 9.3k 1.5× 12.9k 2.1× 4.8k 0.9× 1.1k 29.7k
Peter J. Campbell 17.9k 1.8× 8.2k 1.1× 5.6k 0.9× 6.4k 1.0× 3.2k 0.6× 251 31.8k
Thomas E. Witzig 11.2k 1.2× 8.6k 1.2× 13.5k 2.1× 9.6k 1.6× 14.1k 2.6× 778 34.1k
Jeffery L. Kutok 11.3k 1.2× 2.6k 0.4× 5.8k 0.9× 3.5k 0.6× 3.3k 0.6× 192 21.4k
Louis M. Staudt 15.4k 1.6× 6.3k 0.8× 9.4k 1.5× 2.4k 0.4× 10.8k 2.0× 293 34.8k
Donna Neuberg 14.4k 1.5× 9.4k 1.3× 14.0k 2.2× 12.4k 2.0× 11.3k 2.1× 719 46.3k
John G. Gribben 5.0k 0.5× 9.2k 1.2× 8.4k 1.3× 5.1k 0.8× 8.8k 1.6× 481 24.1k
Mark D. Minden 12.1k 1.2× 2.9k 0.4× 7.0k 1.1× 8.3k 1.4× 1.5k 0.3× 509 23.6k
L. Jeffrey Medeiros 9.2k 0.9× 10.3k 1.4× 14.3k 2.2× 7.7k 1.3× 18.8k 3.5× 1.3k 40.1k
Peter Lichter 19.4k 2.0× 11.9k 1.6× 6.7k 1.1× 2.3k 0.4× 7.5k 1.4× 490 36.6k

Countries citing papers authored by Axel Benner

Since Specialization
Citations

This map shows the geographic impact of Axel Benner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Benner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Benner more than expected).

Fields of papers citing papers by Axel Benner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Benner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Benner. The network helps show where Axel Benner may publish in the future.

Co-authorship network of co-authors of Axel Benner

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Benner. A scholar is included among the top collaborators of Axel Benner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Benner. Axel Benner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jahn, Nikolaus, Maral Saadati, Pierre Fenaux, et al.. (2023). Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia. 37(11). 2187–2196. 22 indexed citations
3.
Nagai, Tomoaki, Andrey Turchinovich, Natália Becker, et al.. (2016). Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization. Cancer Research. 76(22). 6690–6700. 23 indexed citations
4.
Henrich, Kai-Oliver, Sebastian Bender, Maral Saadati, et al.. (2016). Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas. Cancer Research. 76(18). 5523–5537. 73 indexed citations
5.
Mudduluru, Giridhar, Mohammed Abba, Jasmin Batliner, et al.. (2015). A Systematic Approach to Defining the microRNA Landscape in Metastasis. Cancer Research. 75(15). 3010–3019. 50 indexed citations
6.
Steinert, Gunnar, Sebastian Schölch, Thomas Niemietz, et al.. (2014). Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer. Cancer Research. 74(6). 1694–1704. 194 indexed citations
7.
Bochtler, Tilmann, Friedrich Stölzel, Christoph E. Heilig, et al.. (2013). Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia. Journal of Clinical Oncology. 31(31). 3898–3905. 51 indexed citations
8.
Madhavan, Dharanija, Manuela Zucknick, Markus Wallwiener, et al.. (2012). Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer. Clinical Cancer Research. 18(21). 5972–5982. 214 indexed citations
9.
Holzinger, Dana, Markus Schmitt, Gerhard Dyckhoff, et al.. (2012). Viral RNA Patterns and High Viral Load Reliably Define Oropharynx Carcinomas with Active HPV16 Involvement. Cancer Research. 72(19). 4993–5003. 134 indexed citations
10.
Henrich, Kai‐Oliver, Tobias Bauer, Johannes H. Schulte, et al.. (2011). CAMTA1 , a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells. Cancer Research. 71(8). 3142–3151. 64 indexed citations
11.
Remke, Marc, Thomas Hielscher, Paul A. Northcott, et al.. (2011). Adult Medulloblastoma Comprises Three Major Molecular Variants. Journal of Clinical Oncology. 29(19). 2717–2723. 160 indexed citations
12.
Kvinlaug, Brynn T., Lars Bullinger, Mukundhan Ramaswami, et al.. (2011). Common and Overlapping Oncogenic Pathways Contribute to the Evolution of Acute Myeloid Leukemias. Cancer Research. 71(12). 4117–4129. 37 indexed citations
13.
Halama, Niels, Sara Michel, Matthias Kloor, et al.. (2011). Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy. Cancer Research. 71(17). 5670–5677. 321 indexed citations
14.
Traenka, Christopher, Marc Remke, Andrey Korshunov, et al.. (2010). Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma. Cancer Research. 70(20). 8003–8014. 55 indexed citations
15.
Pfister, Stefan M., Marc Remke, Axel Benner, et al.. (2009). Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci. Journal of Clinical Oncology. 27(10). 1627–1636. 198 indexed citations
16.
Luft, Thomas, Michael Conzelmann, Axel Benner, et al.. (2007). Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood. 110(13). 4535–4542. 79 indexed citations
17.
Westermann, Frank, Kai-Oliver Henrich, Jun S. Wei, et al.. (2007). High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status. Clinical Cancer Research. 13(16). 4695–4703. 39 indexed citations
18.
19.
Göerner, Martin, et al.. (2003). Unrelated Donor Transplantation after Reduced Intensity Conditioning as an Approach for Patients Lacking Related Donors for Allogeneic Stem Cell Transplantation. Journal of Hematotherapy & Stem Cell Research. 12(3). 331–339. 2 indexed citations
20.
Konstantinov, Spiro, Margarita Topashka-Ancheva, Axel Benner, & Martin R. Berger. (1998). Alkylphosphocholines: Effects on human leukemic cell lines and normal bone marrow cells. International Journal of Cancer. 77(5). 778–786. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Martinelli Breakdown of academic impact, for papers by Peter J. Campbell Breakdown of academic impact, for papers by Thomas E. Witzig Breakdown of academic impact, for papers by Jeffery L. Kutok Breakdown of academic impact, for papers by Louis M. Staudt Breakdown of academic impact, for papers by Donna Neuberg Breakdown of academic impact, for papers by John G. Gribben Breakdown of academic impact, for papers by Mark D. Minden Breakdown of academic impact, for papers by L. Jeffrey Medeiros Breakdown of academic impact, for papers by Peter Lichter
Rankless by CCL
2026